Literature DB >> 3118498

Diabetes mellitus as a hypercoagulable state: its relationship with fibrin fragments and vascular damage.

L J García Frade1, H de la Calle, I Alava, J L Navarro, L J Creighton, P J Gaffney.   

Abstract

Haemostatic variables were assessed in 43 patients, 28 insulin-dependent and 15 non insulin-dependent. Maximum aggregation by low concentrations of adenosine diphosphate (ADP) or arachidonic acid and elevated plasma concentrations of TxB2, Factor VIII, vWF:Ag, RCoF and fibronectin (Fnct) indicated a hypercoagulable state. The manifestation of vasculopathy was associated with elevated concentrations of RCoF, Fnct, Hbalc, cholesterol and triglycerides, while impaired fibrinolysis was demonstrated by decreased t-PA levels and the absence of crosslinked fibrin degradation products (XL-FDP).

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3118498     DOI: 10.1016/0049-3848(87)90358-6

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  14 in total

1.  Losartan and simvastatin inhibit platelet activation in hypertensive patients.

Authors:  Shosaku Nomura; Akira Shouzu; Seitarou Omoto; Mitsushige Nishikawa; Shirou Fukuhara; Toshiji Iwasaka
Journal:  J Thromb Thrombolysis       Date:  2004-12       Impact factor: 2.300

2.  Significance of chemokines and activated platelets in patients with diabetes.

Authors:  S Nomura; A Shouzu; S Omoto; M Nishikawa; S Fukuhara
Journal:  Clin Exp Immunol       Date:  2000-09       Impact factor: 4.330

Review 3.  How does blood glucose control with insulin save lives in intensive care?

Authors:  Greet Van den Berghe
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

4.  Prediction of clinical course in diabetes using a simple coagulation test.

Authors:  C R Spillert; V J Milazzo; J A Pastena; E J Lazaro
Journal:  J Natl Med Assoc       Date:  1989-01       Impact factor: 1.798

5.  Effect of acarbose on platelet-derived microparticles, soluble selectins, and adiponectin in diabetic patients.

Authors:  Takayuki Shimazu; Norihito Inami; Daisuke Satoh; Takayuki Kajiura; Kohichi Yamada; Toshiji Iwasaka; Shosaku Nomura
Journal:  J Thromb Thrombolysis       Date:  2009-01-10       Impact factor: 2.300

Review 6.  Clinical potential of insulin therapy in critically ill patients.

Authors:  Dieter Mesotten; Greet Van den Berghe
Journal:  Drugs       Date:  2003       Impact factor: 9.546

7.  Intensive care management of critically sick diabetic patients.

Authors:  Sukhminder Jit Singh Bajwa
Journal:  Indian J Endocrinol Metab       Date:  2011-10

8.  Effects of miglitol in platelet-derived microparticle, adiponectin, and selectin level in patients with type 2 diabetes mellitus.

Authors:  Shosaku Nomura; Seitaro Omoto; Takashi Yokoi; Shinya Fujita; Ryotaro Ozasa; Noritaka Eguchi; Akira Shouzu
Journal:  Int J Gen Med       Date:  2011-07-20

9.  A hypothesis-generating study to evaluate platelet activity in diabetics with chronic kidney disease.

Authors:  Donald F Brophy; Rika J Martin; Todd Wb Gehr; Marcus E Carr
Journal:  Thromb J       Date:  2005-03-29

10.  Anti-atherosclerotic effects of sitagliptin in patients with type 2 diabetes mellitus.

Authors:  Seitaro Omoto; Takehito Taniura; Tohru Nishizawa; Takeshi Tamaki; Akira Shouzu; Shosaku Nomura
Journal:  Diabetes Metab Syndr Obes       Date:  2015-07-27       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.